
384: Live from the JP Morgan conference, a sit-down with Novo Nordisk's CEO and VC Bob Nelsen
The Readout Loud
00:00
DTC growth versus insured channels
Mike compares cash channel growth to insured channels and describes Novo's current DTC share.
Play episode from 21:54
Transcript


